WVU RNI announces breakthrough in treating Alzheimer’s using targeted drug delivery
A first in-human study at the WVU Rockefeller Neuroscience Institute demonstrates the benefits of combining focused ultrasound with antibody treatment to reduce brain amyloid plaques in patients with Alzheimer’s disease. The study is featured in the latest issue of the New England Journal of Medicine.